4.6 Review

The Role of Bioactive Compounds on the Promotion of Neurite Outgrowth

期刊

MOLECULES
卷 17, 期 6, 页码 6728-6753

出版社

MDPI
DOI: 10.3390/molecules17066728

关键词

neurite outgrowth; neuroregeneration; neuritogenesis; natural molecules; neurodegeneration

资金

  1. High Value-added Food Technology Development Program
  2. Ministry for Food, Agriculture, Forestry, and Fisheries
  3. Regional Innovation Center (RIC) Program of the Ministry of Knowledge Economy through the Bio-Food & Drug Research Center at Konkuk University, Korea

向作者/读者索取更多资源

Neurite loss is one of the cardinal features of neuronal injury. Apart from neuroprotection, reorganization of the lost neuronal network in the injured brain is necessary for the restoration of normal physiological functions. Neuritogenic activity of endogenous molecules in the brain such as nerve growth factor is well documented and supported by scientific studies which show innumerable compounds having neurite outgrowth activity from natural sources. Since the damaged brain lacks the reconstructive capacity, more efforts in research are focused on the identification of compounds that promote the reformation of neuronal networks. An abundancy of natural resources along with the corresponding activity profiles have shown promising results in the field of neuroscience. Recently, importance has also been placed on understanding neurite formation by natural products in relation to neuronal injury. Arrays of natural herbal products having plentiful active constituents have been found to enhance neurite outgrowth. They act synergistically with neurotrophic factors to promote neuritogenesis in the diseased brain. Therefore use of natural products for neuroregeneration provides new insights in drug development for treating neuronal injury. In this study, various compounds from natural sources with potential neurite outgrowth activity are reviewed in experimental models.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

Targeting α-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease

Md Ezazul Haque, Mahbuba Akther, Shofiul Azam, In-Su Kim, Yuxi Lin, Young-Ho Lee, Dong-Kug Choi

Summary: In Parkinson's disease, the aggregated alpha-synuclein in Lewy bodies and mitochondrial dysfunction play crucial roles in neurodegeneration, with interactions between aggregated alpha-synuclein and mitochondria potentially leading to neuronal loss, making it an emerging drug target for Parkinson's disease treatment.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Review Biochemistry & Molecular Biology

Molecular Mechanisms and Therapeutic Potential of α- and β-Asarone in the Treatment of Neurological Disorders

Rengasamy Balakrishnan, Duk-Yeon Cho, In-Su Kim, Sang-Ho Seol, Dong-Kug Choi

Summary: Neurological disorders are an important global health issue, and there is a lack of effective treatment options. Alpha- and beta-asarone, secondary metabolites found in plants, show potential neuroprotective effects. They act through multiple mechanisms, including antioxidant, anti-inflammatory, and antiapoptotic effects, making them a promising therapeutic approach for neurodegenerative diseases.

ANTIOXIDANTS (2022)

Review Biochemistry & Molecular Biology

Microtubule Dynamics Following Central and Peripheral Nervous System Axotomy

Riya Kulkarni, Akshata Thakur, Hemant Kumar

Summary: Disturbance in the neuronal network can lead to instability in microtubules, hindering intra-axonal transport and making it difficult to reestablish the broken network. Peripheral nervous system neurons have the ability to stabilize microtubules, while central nervous system neurons form growth-incompetent structures. Understanding microtubule dynamics is crucial in developing therapeutic strategies for diseases involving disrupted microtubule networks.

ACS CHEMICAL NEUROSCIENCE (2022)

Article Pharmacology & Pharmacy

Cytoskeleton saga: Its regulation in normal physiology and modulation in neurodegenerative disorders

Santimoy Sen, Sheetal Lagas, Abhishek Roy, Hemant Kumar

Summary: Cells rely on a balanced cytoskeleton to maintain cellular integrity and regulate signaling pathways. Dysregulation of the cytoskeleton can lead to various pathological conditions, and targeting cytoskeletal dynamics may provide new therapeutic approaches for these diseases.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Review Cell Biology

The Provenance, Providence, and Position of Endothelial Cells in Injured Spinal Cord Vascular Pathology

Manjeet Chopra, Ankita Bhagwani, Hemant Kumar

Summary: Endothelial cells and pericytes play important roles in blood vessels, with their interaction crucial for angiogenesis and wound healing. Understanding the surface markers, spatiotemporal association, and signaling pathways associated with traumatic spinal cord injury can lead to the identification of new therapeutic targets and preventive strategies.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2023)

Article Biochemistry & Molecular Biology

In Vivo and 3D Imaging Technique(s) for Spatiotemporal Mapping of Pathological Events in Experimental Model(s) of Spinal Cord Injury

Divya Goyal, Hemant Kumar

Summary: Endothelial damage, astrogliosis, microgliosis, and neuronal degeneration are common events after spinal cord injury (SCI). Conventional techniques like 2-dimensional histology and immunohistochemistry (IHC) are used to visualize and detect these events, but advanced imaging methodologies such as two-photon imaging and in vivo chemical and fluorescent protein-expressing viral-tracers offer more advantages in terms of tissue sectioning, 3D reconstructed imaging, and minimal invasiveness. This review discusses the future development of these advanced imaging techniques to explore the fundamental mechanisms after SCI.

ACS CHEMICAL NEUROSCIENCE (2023)

Article Pharmacology & Pharmacy

Peptide Engraftment on PEGylated Nanoliposomes for Bone Specific Delivery of PTH (1-34) in Osteoporosis

Sagar Salave, Suchita Dattatray Shinde, Dhwani Rana, Bichismita Sahu, Hemant Kumar, Rikin Patel, Derajram Benival, Nagavendra Kommineni

Summary: Bone-specific functionalization strategies on liposomes can deliver drugs specifically to the bone surface, reducing the dose and off-target effects of the drug, and thereby reducing its toxicity.

PHARMACEUTICS (2023)

Review Clinical Neurology

Different Ways to Die: Cell Death Pathways and Their Association With Spinal Cord Injury

Lahanya Guha, Nidhi Singh, Hemant Kumar

Summary: Cell death is a complex process involving multiple pathways, some of which have been well-studied while others are still being explored. In neurological diseases, impairments in various programmed cell death signaling processes are observed. Spinal cord injury, characterized by the death of neuronal and glial cells, can be influenced by different cell death pathways. A better understanding of the molecular basis of these pathways may enhance neuronal and glial survival, promoting a curative path for spinal cord injury.

NEUROSPINE (2023)

Review Neurosciences

Building a pathway to recovery: Targeting ECM remodeling in CNS injuries

Ayub Mohammed Butt, Vimal Rupareliya, A. Hariharan, Hemant Kumar

Summary: The extracellular matrix (ECM) is a complex network of macromolecules that surround cells in tissues, providing structural support and regulating cellular functions. ECM remodeling is a dynamic process involved in tissue growth, wound healing, and tissue repair. Dysregulated ECM remodeling can lead to the formation of fibrotic and glial scars in CNS injuries.

BRAIN RESEARCH (2023)

Review Cell Biology

Unraveling the Potential of EphA4: A Breakthrough Target and Beacon of Hope for Neurological Diseases

Meenal Verma, Manjeet Chopra, Hemant Kumar

Summary: This article reviews the role of EphA4 in neurological diseases and discusses its potential as a therapeutic target for CNS diseases. It also provides an overview of multiple signaling pathways that regulate EphA4-associated biological processes.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2023)

Review Pharmacology & Pharmacy

The molecular soldiers of the CNS: Astrocytes, a comprehensive review on their roles and molecular signatures

Vimal P. Rupareliya, Aditya A. Singh, Ayub Mohammed Butt, A. Hariharan, Hemant Kumar

Summary: Astrocytes, with their diverse populations and functions, play essential roles in regulating CNS physiology and are implicated in various neurological and psychiatric disorders. The heterogeneity of astrocytes in morphology, function, and gene expression contributes to their region-specific functions and interactions with neurons. Further investigation into astrocytic heterogeneity may provide new insights and therapeutic approaches for targeting neurological conditions.

EUROPEAN JOURNAL OF PHARMACOLOGY (2023)

Article Immunology

Network analysis identifies strain-dependent response to tau and tau seeding-associated genes

Dominic J. Acri, Yanwen You, Mason D. Tate, Hande Karahan, Pablo Martinez, Brianne Mccord, A. Daniel Sharify, Sutha John, Byungwook Kim, Luke C. Dabin, Stephanie Philtjens, H. R. Sagara Wijeratne, Tyler J. Mccray, Daniel C. Smith, Stephanie J. Bissel, Bruce T. Lamb, Cristian A. Lasagna-Reeves, Jungsu Kim

Summary: Previous research has shown that genetic heterogeneity plays a crucial role in modeling amyloid accumulation and other phenotypes seen in Alzheimer's disease. However, the mechanisms behind the impact of genetic background on the pathogenicity of tau aggregates remain unknown. This study induced tau aggregation in mice with different genetic backgrounds and conducted RNA sequencing to identify key genes associated with tau seeding and amyloid response. The findings suggest that the genetic context of mice affects the alteration of transcriptome and tau seeding, providing valuable resources for better modeling tauopathy.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Review Neurosciences

Role of Axon Guidance Molecules in Ascending and Descending Paths in Spinal Cord Regeneration

Alisha Vartak, Divya Goyal, Hemant Kumar

Summary: Guidance molecules are essential for neural development, particularly in guiding axons to their target regions during spinal cord development. Defects in these molecules' expression or function can lead to abnormalities in axonal pathfinding, growth cone navigation, axonal branching, and synapse formation, affecting neuronal circuit construction and function after central nervous system traumas such as spinal cord injury (SCI).

NEUROSCIENCE (2023)

Review Chemistry, Medicinal

Recent Perspectives on Cardiovascular Toxicity Associated with Colorectal Cancer Drug Therapy

Monu Kumar Kashyap, Shubhada V. Mangrulkar, Sapana Kushwaha, Akash Ved, Mayur B. Kale, Nitu L. Wankhede, Brijesh G. Taksande, Aman B. Upaganlawar, Milind J. Umekar, Sushruta Koppula, Spandana Rajendra Kopalli

Summary: Cardiotoxicity is a well-known adverse effect of cancer-related therapy, and it significantly affects patient outcomes and quality of life. The use of antineoplastic drugs to treat colorectal cancers (CRCs) can result in cardiac complications. The mechanisms underlying cardiotoxicity associated with CRC treatment are complex and involve the modulation of various signaling pathways, ultimately damaging cardiac tissue. Therefore, the identification and management of cardiotoxicity associated with CRC drug therapy have become increasingly important.

PHARMACEUTICALS (2023)

Review Pharmacology & Pharmacy

Drug Repurposing for Spinal Cord Injury: Progress Towards Therapeutic Intervention for Primary Factors and Secondary Complications

Lahanya Guha, Hemant Kumar

Summary: Spinal cord injury (SCI) is a leading cause of morbidity and mortality worldwide, involving complex mechanisms such as cell death pathways, neurodegeneration, glutaminergic transmission, and inflammation. Current treatment options, including corticosteroids and non-steroidal anti-inflammatory drugs, have limitations in their effectiveness and are focused on symptomatic relief. Drug repurposing offers a promising approach to expand therapy alternatives for SCI, utilizing approved drugs with known safety and efficacy data. This review summarizes marketed drugs that could be repurposed and discusses ongoing clinical trials for SCI therapy.

PHARMACEUTICAL MEDICINE (2023)

暂无数据